2. To learn more, call 1.888.586.3747 or visit Lumeris.com
Lumeris’ Board of Directors
• Mike Long, Chairman and Chief Executive Officer, Essence Group Holdings Corporation and Lumeris Corporation
• John Burbank, Managing Member and Chief Investment Officer, Passport Capital
• Denis A. Cortese, MD, President and Chief Executive Officer Emeritus, Mayo Clinic Director, Health Care Delivery
and Policy Program, Arizona State University
• L. John Doerr, Partner, Kleiner Perkins Caufield & Byers
• Matt Downs, Managing Director, Sandbox Industries
• Christopher W. Kersey, MD, MBA, Managing Member, Camden Partners
• John H. Rice, MD, Executive Vice President and Chief Medical Officer, Esse Health
Value-Based
Populations
Medicare Advantage
• Roughly 200,000 lives
under mgmt.
Commercial
• Roughly 500,000 lives
under mgmt.
Self-Insured Employee
• Roughly 55,000 lives
under mgmt.
MSSP ACO
• Two successful MSSP
applications
• Roughly 20k lives
Health Systems
Built a PHSO for a $500M
community health system
managing full risk and SS
contracts
Designed and deployed Care
Management and technology
for $800M health system to
support P4Q and SS contracts
Clinically integrating a seven
hospital, 200 site, 2,100
physician health system to
perform on value-based
contracts
Provider Alliances
Built a PHSO for an alliance
with 3 health systems and
over 200 independent
physicians
Delivered PHSO services for
large regional IPA to improve
performance on value-based
contracts
Built a PHSO for 300+
independent PCPs managing
full-risk Medicare Advantage
contracts
Payers
Delivering PHSO services
for multiple health plans
starting Medicare Advantage
offerings
Providing technology and
services to support a large
regional payer’s accountable
provider strategy
Providing EMR integration
and Risk Adjustment services
for large regional payer
Current Client Engagements
GEN.WMLD.01-16.v1
Proven Outcomes
As a result of our outstanding solutions, we have been able to achieve:
• 5 Stars for the 2016 plan year, and 4.5 Stars the previous four years;
• Nearly 70 percent MCR before surplus distribution of physician quality-based compensation;
• 30 percent reduction in costs and 18 percent reduction in readmission rate compared to FFS Medicare;
• Largest, in-region market share for four years; and
• Over 80 percent of providers consistently rate that they are satisfied with their collaborative payer partner.